Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder
Fortune Minerals Reports Successful NICO Project Bismuth Test Work Results for the Planned Alberta Refinery